Vesnarinone (Arkin, INN) is a mixed phosphodiesterase 3 inhibitor and ion-channel modifier exhibiting dose-dependent positive inotropic effects with minimal heart rate reduction. Its research applications extend to studying p53-mediated cell cycle arrest, as it induces p21 expression to suppress proliferation and promote apoptosis in vitro.